Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol in hypertensive COPD patients
NCT01939990Phase 3Withdrawn
- Sponsor
- University of Chicago
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nebivolol in hypertension (HTN), sponsored by University of Chicago. Planned start Jan 2012; status: withdrawn.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01939990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939990.